A Case Report | Open Access
Volume 2024 - 3 | Article ID 242 | http://dx.doi.org/10.51521/WJCRCI.2024.31-224
Academic Editor: Wendy Yeo
Patricia
Stevenson*, Kristie Warwick, Kerry Wirz, Chelsea Birtwell
Corresponding Author: *Patricia Stevenson, Next Science
Citation: Patricia Stevenson, Kristie Warwick, Kerry Wirz,
Chelsea Birtwell (2024). Case Report: BLASTX® Antimicrobial Wound Gel Treatment
in Sweets Syndrome with Lymphedema: A Comprehensive Case Presentation. World J
Case Rep Clin Imag. 2024 Jan-Feb; 3(1)1-5.
Copyrights: © 2024, Patricia Stevenson, et al. This article is
licensed under the Creative Commons Attribution-Non-Commercial-
4.0-International-License-(CCBY-NC) (https://worldjournalofcasereports.org/bl
ogpage/copyright-policy). Usage and distribution for commercial purposes
require written permission.
Abstract
Sweets
Syndrome (SS), a rare autoinflammatory skin condition, presents challenges in
wound management. This case study explores a patient with SS complicated by
lymphedema, highlighting the efficacy of BLASTX® treatment. SS, marked by fever
and painful skin lesions, often accompanies immune system dysregulation.
Chronic ulcers associated with autoinflammatory diseases serve as significant
diagnostic indicators. This report examines the case, emphasizing the role of
BLASTX® Antimicrobial Wound Gel in managing SS-related cutaneous ulcers.
Keywords: Sweets Syndrome, BLASTX® treatment, Lymphedema, Autoinflammatory
diseases, Wound management
.png)
.jpg)
.gif)
.jpg)
